Activation of 5-HT2 receptors inhibits the evoked release of [3H]noradrenaline in the rat spinal cord

Gen Pharmacol. 1992 Nov;23(6):1063-5. doi: 10.1016/0306-3623(92)90287-t.

Abstract

1. The participation of 5-HT2 receptors in the modulation of the evoked release of [3H]noradrenaline from rat spinal cord slices has been examined. 2. In rat spinal cord slices preincubated with [3H]noradrenaline, the alpha 2-receptor agonist clonidine (10(-6) mol/l) decreased the release of tritium evoked by field stimulation (600 pulses at 5 Hz, 20 mA, 2 msec), while the alpha 2-antagonist yohimbine (10(-6) mol/l) increased it. 3. The 5-HT2/5-HT1c agonist DOI (3 x 10(-7) mol/l) decreased the evoked release of tritium, an effect which was prevented by ketanserin (10(-7) mol/l). 4. It is suggested that in addition to presynaptic alpha 2-adrenoceptors, there are 5-HT2 receptors which modulate the release of noradrenaline in the rat spinal cord.

MeSH terms

  • Amphetamines / pharmacology
  • Animals
  • Clonidine / pharmacology
  • Electric Stimulation
  • Female
  • Hallucinogens / pharmacology
  • In Vitro Techniques
  • Ketanserin / pharmacology
  • Norepinephrine / metabolism*
  • Rats
  • Rats, Wistar
  • Receptors, Adrenergic, alpha / drug effects
  • Receptors, Adrenergic, alpha / metabolism
  • Serotonin Receptor Agonists / pharmacology*
  • Spinal Cord / drug effects
  • Spinal Cord / metabolism*
  • Yohimbine / pharmacology

Substances

  • Amphetamines
  • Hallucinogens
  • Receptors, Adrenergic, alpha
  • Serotonin Receptor Agonists
  • Yohimbine
  • Ketanserin
  • Clonidine
  • 4-iodo-2,5-dimethoxyphenylisopropylamine
  • Norepinephrine